Keloids Treatment Market Report 2026

The keloids treatment market size has grown steadily in recent years. It will grow from $4.32 billion in 2025 to $4.48 billion in 2026 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to increasing incidence of skin injuries and surgeries, growing prevalence of keloid-prone populations, established use of steroid injections, rising demand for cosmetic dermatology treatments, availability of multiple treatment modalities.

The keloids treatment market size is expected to see steady growth in the next few years. It will grow to $5.37 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to advancement in laser and cryotherapy technologies, growing awareness of scar management solutions, rising preference for minimally invasive treatments, expansion of dermatology clinics in emerging markets, increasing adoption of homecare scar products. Major trends in the forecast period include rising demand for non-invasive keloid treatments, growing adoption of combination therapy approaches, increasing use of laser-based scar management, expansion of homecare and topical treatment options, focus on personalized and recurrence-preventive therapies.

The increasing occurrence of wounds and injury cases is expected to drive the growth of the keloid treatment market in the coming years. A wound is a physical harm or damage to the body's tissues, generally involving a break in the skin, caused by various factors such as accidents, surgical procedures, burns, or other traumatic events. The increase in wounds leads to keloid formation, boosting the demand for effective treatment options, raising awareness about keloid complications, encouraging research developments, and promoting collaboration among healthcare professionals. For example, in November 2024, according to the U.S. Bureau of Labor Statistics (BLS), a US-based federal government agency that produces key labor market and workplace safety data, private industry employers reported approximately 2.6 million nonfatal workplace injuries and illnesses in 2023. Consequently, the rising occurrence of wounds and injury cases will support the growth of the keloid treatment market.

The growing interest in non-surgical aesthetic treatments is expected to drive the growth of the keloid treatment market. Non-surgical aesthetics involve cosmetic procedures that improve appearance without the need for surgery, targeting specific concerns to achieve a more youthful look. Healthcare providers utilize non-surgical aesthetic procedures, including laser therapy, cryotherapy, and dermal fillers, to reduce the appearance and symptoms of keloid scars, minimizing inflammation, redness, and vascularization. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit organization representing board-certified plastic surgeons, reported that total surgical and non-surgical aesthetic procedures increased by 3.4% in 2023, reaching approximately 34.9 million, with around 19.1 million being non-surgical treatments. Consequently, the rising demand for non-surgical aesthetic procedures is expected to propel the keloid treatment market.

Major companies in the keloid treatment market are concentrating on developing innovative scar management technologies, such as scar-erase silicone strips, to achieve a competitive edge. For example, in April 2023, Scar Erase, a UK-based scar treatment company, introduced Scar Erase silicone strips as a solution for scar treatment. These strips are made from 3 mm of medical-grade silicone and have been clinically proven to enhance scar appearance and support healing. These reusable, vegan, and cruelty-free technology strips are designed to provide an affordable and convenient at-home scar treatment option suitable for various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. The technology involves encapsulating the scar with silicone to hydrate it and create an optimal healing environment. This process reduces collagen formation and improves scar texture, color, and height, offering both effectiveness and comfort.

Major companies operating in the keloids treatment market are Galderma S.A., Sun Pharmaceutical Industries Ltd., Stratpharma AG, Revance Therapeutics Inc., Sensus Healthcare Inc., Cynosure Inc., Cutera Inc., Lumenis Ltd., Candela Medical, Merz Pharma GmbH & Co. KGaA, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alliance Pharma plc, Sonoma Pharmaceuticals Inc., Strata Skin Sciences Inc., Avita Medical Limited, Biofrontera AG, Sinclair Pharma plc, Fotona d.o.o., Lutronic Corporation.

North America was the largest region in the keloids treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the keloids treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the keloids treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have moderately impacted the keloids treatment market by increasing costs of imported laser devices, cryotherapy equipment, and specialized dermatology consumables. Treatment segments such as laser therapy, radiation therapy, and interferon-based treatments are most affected, particularly in north america and europe due to dependence on cross-border medical device manufacturing. Hospitals and dermatology clinics face higher procurement and maintenance costs, which may influence treatment pricing. However, tariffs have encouraged localized manufacturing of dermatology devices, strengthened regional supply chains, and supported long-term cost optimization for keloid treatment solutions.

The keloids treatment market research report is one of a series of new reports that provides keloids treatment market statistics, including keloids treatment industry global market size, regional shares, competitors with a keloids treatment market share, detailed keloids treatment market segments, market trends and opportunities, and any further data you may need to thrive in the keloids treatment industry. This keloids treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Keloids are raised, thickened scars that extend beyond the original boundaries of a wound or injury. These scars occur due to an excessive buildup of collagen during the healing process, resulting in a firm, often discolored area that can sometimes be uncomfortable or itchy. Keloids can be managed with various medical interventions and approaches based on the individual's condition and the severity of the keloid.

The primary types of keloid treatments include radiation therapy, cryotherapy, surgical treatment, laser treatment, steroid injections, interferon, and others. Radiation therapy is a medical procedure that delivers high doses of targeted radiation to abnormal cells, such as keloid cells, aiming to inhibit cell overgrowth and reduce keloid size. This also helps prevent recurrence by damaging the cells responsible for keloid formation. Keloid management also involves products such as elastic wraps, sprays, ointments, creams, oils, topical gels, gel sheets, and others, which are administered orally or parenterally by end users, including hospitals, homecare providers, dermatology clinics, and others.

The keloids treatment market consists of revenues earned by entities by providing dermatology consultations, follow-up and monitoring and patient education and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The keloids treatment market also includes sales of topical creams and gels, silicone sheets and patches and dermal fillers, which are used in keloids treatment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.